D. E. Shaw & Co., Inc. Third Harmonic Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$8.6 - $11.24 $19,031 - $24,874	2,213 Added 8.27%	28,974 $273,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $11.47 $159,763 - $306,948	26,761 New	26,761 $293,000

Others Institutions Holding THRD

# of Institutions

74

Shares Held

40.2M

Call Options Held

9.1K

Put Options Held

0

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$142 Million
18.89% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$75.4 Million
1.81% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$56.9 Million
1.74% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$41.5 Million
1.46% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$38.6 Million
1.22% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $526M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.